_1528963970399.png?format=webp&height=120&width=120){kind=logo}
VSense - About the company
VSense is a funded company based in Israel, founded in 2004. It operates as a Developer of semiconductor biosensor technology. The company has 137 active competitors, including 33 funded and 9 that have exited. Its top competitors include companies like Atrys, DermaSensor and Monod.
Company Details
Vsense is a biosensor developer company and has developed VSensor semiconductor biosensor technology based on bioFET which integrates biomolecule probes with highly sensitive field-effect transistor (FET) sensors to produce quantitative measures of the target antigens. It delivers results within fifteen minutes. VSensor analyzer can be used to perform varieties of assays by inserting different assay cartridge. It can predict lab-quality results with just one drop of blood and assay is delivered on the patient EMR. It can also perform many assays by just inserting a different assay cartridge.
Key Metrics
Sign up to download VSense's company profile
VSense's funding and investors
VSense is a funded company. VSense has 2 institutional investors.
View details of VSense's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
VSense's Competitors and alternates
Top competitors of VSense include Atrys, DermaSensor and Monod. Here is the list of Top 10 competitors of VSense, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of diagnostic and therapeutic services catering to cancer | - | 64/100 | ||
2nd | _1541748952011.png?devicePixelRatio=2&height=30&width=30){kind=logo} DermaSensor 2009, Miami (United States), Series B | Developer of an AI-powered skin cancer detection device | $65.7M | 61/100 | |
3rd |  Monod 2021, Seattle (United States), Seed | Developer of biosensors to detect viral proteins, toxins, antibodies, and other molecules | $25M | 54/100 | |
4th |  Hememics Biotechnologies 2009, Gaithersburg (United States), Seed | Developer of techology platform for biopreservation | $4.6M | 50/100 | |
5th | Cardea Bio 2019, San Diego (United States), Acquired | Developer of digital graphene biosensors using ML | $21.8M | 49/100 | |
6th | Nanopath 2019, Cambridge (United States), Series A | Provider of point-of-care molecuolar diagnostic platform for womens health | $10M | 48/100 | |
7th | Zerigo Health 2014, San Diego (United States), Series B | Developer of UVB light therapy devices for monitoring Psoriasis, Vitiligo, and Eczema | $77.9M | 45/100 | |
8th | Roswell 2015, San Diego (United States), Series A | Provider of diagnostic sensor solutions for nucleic acid sequencing | $32M | 44/100 | |
9th |  The Wave Talk 2016, Seoul (South Korea), Seed | Developer of biosensors to detect and monitor micro-organisms | $2M | 43/100 | |
10th |  Range Bio 2022, San Carlos (United States), Seed | Provider of solutions for health monitoring based on translational proteomics | $5.2M | 42/100 | |
60th | Developer of semiconductor biosensor technology | - | 27/100 |
_1528963970399.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on VSense's competitors? Click here to see the top ones
VSense's Investments and acquisitions
VSense has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about VSense
Explore our recently published companies
- Toodrop - 2026 founded, Unfunded company
- Novo Movil - Spain based, Unfunded company
- Appu Auto - Pune based, 2008 founded, Unfunded company
- Giken Service - Gifu based, 1963 founded, Unfunded company
- Global Financial - Orlando based, Unfunded company
- Joseph Christy Vineyards - United States based, Unfunded company
